CDH2 and breast cancer: The increased expression of E-CAD may not necessarily imply a decrease in the potential to undergo EMT, as there is evidence that E-CAD is a necessary protein for metastasis in breast cancer [42] and that high levels of N-CAD promote cell motility in breast cancer, despite high levels of E-CAD expression [43].